Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer.
Explore this paper's citation graph
Summary
The expression and prognostic impact of the angiogenic growth factors, vascular endothelial growth factor and basic fibroblast growth factor, in NSCLC are reviewed.
- Type
- review
- Published
- 2012-11-01
- Cited by
- 74
- References
- 117
- OpenAlex
- https://openalex.org/W2013205981
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:46688689
Keywords
VEGF receptors, Oncology, Cancer, Lung cancer, Cancer research
References
- Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia.
- Prognostic value of vascular endothelial growth factor and its receptor Flt‐1 in squamous cell lung cancer
- Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
- Basic fibroblast growth factor (FGF‐2): The high molecular weight forms come of age
- [VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis].
- Mechanisms of angiogenesis and arteriogenesis
- VEGF et survie des patients atteints d'un cancer pulmonaire
- Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.
- The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.
- Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
- Mechanisms of angiogenesis
- Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.
- Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
- Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
- Clinical implications of circulating angiogenic factors in cancer patients.
- Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer.
- Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer.
- Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma.
- Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
- Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor size.
Cited by
- Relationship Between Serum VEGF Level and Radiosensitivity of Patients with Nonsmall Cell Lung Cancer Among Asians: A Meta-Analysis
- Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features
- Investigation of the MUC1-independent action of circulating galectins in metastasis promotion
- Basic fibroblast growth factor shows prognostic impact on survival in operable non-small cell lung cancer patients
- Traditional Chinese Medicine: Salvia miltiorrhiza Enhances Survival Rate of Autologous Adipose Tissue Transplantation in Rabbit Model
- Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway
- Association of the FAM46A Gene VNTRs and BAG6 rs3117582 SNP with Non Small Cell Lung Cancer (NSCLC) in Croatian and Norwegian Populations
- MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2
- Jinshuixian in combination with radiotherapy suppresses the proliferation of A549 cells by inhibiting the expression of VEGF
- GHRH antagonist inhibits focal adhesion kinase (FAK) and decreases expression of vascular endothelial growth factor (VEGF) in human lung cancer cells in vitro.
- Increased pro-angiogenic factors, infiltrating neutrophils and CD163(+) macrophages in bronchoalveolar lavage fluid from lung cancer patients.
- Simultaneous Irradiation of Fibroblasts and Carcinoma Cells Repress the Secretion of Soluble Factors Able to Stimulate Carcinoma Cell Migration
- A Genetic Polymorphism in pre-miR-27a Confers Clinical Outcome of Non-Small Cell Lung Cancer in a Chinese Population
- Cutaneous manifestations of anti-angiogenic therapy in oncology: Review with focus on VEGF inhibitors.
- Synergistic effect of RhBMP-2 and bFGF on ectopic osteogenesis in mice.
- Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration.
- Prognostic impact of Raf‐1 and p‐Raf‐1 expressions for poor survival rate in non‐small cell lung cancer
- A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer
- Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: antiangiogenic activity study.
- The effect of Lfcin-B on non-small cell lung cancer H460 cells is mediated by inhibiting VEGF expression and inducing apoptosis
Related papers
- Molecular Epidemiology of Female Lung Cancer
- Electrochemical biosensors for the detection of lung cancer biomarkers: A review.
- The Expression and Clinical Significance of Adrenomedulin in Patients with Lung Cancer
- Chemoprevention of lung cancer.
- 肺癌的性别差异及机制
- Molecular genetics of lung cancer in people who have never smoked.
- Supplementary Figures S1-S6 from Sustained VEGF Blockade Results in Microenvironmental Sequestration of VEGF by Tumors and Persistent VEGF Receptor-2 Activation
- A Review of the Statistical Evidence on the Association Between Smoking and Lung Cancer
- Abstract B31: Gene-based lung cancer risk test (Respiragene), identifies high-risk smokers for early detection of lung cancer